In his report dated June 10, Tan rated DBS with a “sell” call and a target price of $26.60. His target price is based on his FY2023 – FY2024 P/B of 1.12x.

Tan’s “sell” call comes on the back of risks to the bank’s net interest income (NII) as its average interest earning assets (AIEA) could fall below the consensus estimate of $653 billion for FY2023, which is up by 5% y-o-y.

In the 1QFY2023 ended March 31, DBS’s AIEA stood at $617 billion, down 4% q-o-q.

Loan growth risk is another downside factor for Tan as he sees the bank’s loans from Greater China (making up about 30% of the bank’s total loans) remaining soft with onshore lending rates still low.

Finally, DBS’s superior return on equity (ROE) to its peers could narrow on higher taxes and provisions as well as a reversal in a $5.2 billion swing in fair-value reserves, which lifted the bank’s FY2022 ROE by 67 basis points (bps).

See also: <a class='gtm_see_also_1_inread' style='text-decoration: underline;' href='/capital/brokers-calls/dbs-upgrades-grab-buy-higher-tp-us429?utm_source=website&utm_medium=article&utm_campaign=ONPAGESEO'>DBS upgrades Grab to ‘buy’ with higher TP of US$4.29</a>

In spite of the negatives, the analyst has recognised DBS’s early digital transformation and its focus on shareholder returns.

“OCBC’s earnings have [a] lower risk. Its 1QFY2023 AIEA was closer to FY2023 cons and its Greater China loans are a smaller share of the total,” says Tan.

See also: <a class='gtm_see_also_2_inread' style='text-decoration: underline;' href='/capital/brokers-calls/citi-downgrades-sgx-sell-lower-tp-9?utm_source=website&utm_medium=article&utm_campaign=ONPAGESEO'>Citi downgrades SGX to ‘sell’ with lower TP of $9</a>

He adds: “OCBC could positively surprise on [its] 1HFY2023 dividend per share (DPS), based on a 50% payout ratio plan and targeted 14% common equity tier 1 (CET-1) ratio plus ongoing risk-weighted assets (RWA) optimisation.”

With its share price trading at below 1x P/B, OCBC offers valuation support, in Tan’s view.

That said, Tan is also remaining “neutral” on OCBC with a higher target price of $12.50 from $12.20 previously.

“In a global downturn or recession, Singapore suffers given its large exposure to developed markets. DBS and OCBC tend to suffer and lose any premium over 1x P/B,” he writes.

“In the past two downcycles, DBS / OCBC valuations fell to 0.8x P/B. With OCBC currently trading below [its] book value, we believe it has downside support. Our economists forecast a US recession in 4Q2023-1Q2024,” he adds.

Shares in DBS and OCBC closed at $31.25 and $12.38 respectively on June 12.

Citi reinstates coverage on DBS with 'sell' call and target price of $26.60

Will the Rising Sun keep rising?

Fed signals higher-for-longer rates with hikes almost finished

EQT Impact Challenge offers platform for impact entrepreneurs to attain 'patient capital'

Singtel to sell 20% stake in regional data centre business valued at $5.5 bil

SoftBank has either reopened the IPO market or killed it

Citi reinstates coverage on DBS with 'sell' call and target price of $26.60

Related News

Highlights

Will the Rising Sun keep rising?

Related News

OCBC becomes direct clearing member of HKEX’S OTC Clear AND LCH SwapClear

Citi downgrades SGX to ‘sell’ with lower TP of $9

Credit quality of OCBC’s SME loans may be risk to the bank